- Home
- ALKT vs BHC Comparison
ALKT vs BHC Comparison
Compare ALKT & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKT
- BHC
- Stock Information
- Founded
- ALKT 2007
- BHC N/A
- Country
- ALKT United States
- BHC Canada
- Employees
- ALKT N/A
- BHC N/A
- Industry
- ALKT EDP Services
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ALKT Technology
- BHC Health Care
- Exchange
- ALKT Nasdaq
- BHC Nasdaq
- Market Cap
- ALKT 2.3B
- BHC 2.5B
- IPO Year
- ALKT 2021
- BHC N/A
- Fundamental
- Price
- ALKT $22.41
- BHC $7.78
- Analyst Decision
- ALKT Buy
- BHC Hold
- Analyst Count
- ALKT 9
- BHC 2
- Target Price
- ALKT $39.89
- BHC $9.00
- AVG Volume (30 Days)
- ALKT 1.8M
- BHC 4.4M
- Earning Date
- ALKT 07-30-2025
- BHC 07-30-2025
- Dividend Yield
- ALKT N/A
- BHC N/A
- EPS Growth
- ALKT N/A
- BHC N/A
- EPS
- ALKT N/A
- BHC 0.27
- Revenue
- ALKT $385,456,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- ALKT $36.31
- BHC $5.53
- Revenue Next Year
- ALKT $25.07
- BHC $3.70
- P/E Ratio
- ALKT N/A
- BHC $29.39
- Revenue Growth
- ALKT 29.63
- BHC 7.13
- 52 Week Low
- ALKT $19.94
- BHC $4.25
- 52 Week High
- ALKT $42.29
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ALKT 41.11
- BHC 65.68
- Support Level
- ALKT $22.43
- BHC $5.68
- Resistance Level
- ALKT $23.47
- BHC $8.69
- Average True Range (ATR)
- ALKT 1.22
- BHC 0.43
- MACD
- ALKT 0.23
- BHC 0.20
- Stochastic Oscillator
- ALKT 46.58
- BHC 71.47
About ALKT Alkami Technology Inc.
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company's solution, the Alkami Digital Banking Platform, allows FIs to onboard and engage new users, accelerate revenues and meaningfully improve operational efficiency, all with the support of a proprietary, true cloud-based, multi-tenant architecture.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.